Xylem (NYSE:XYL) Price Target Raised to $138.00 at TD Cowen

Xylem (NYSE:XYLFree Report) had its price target lifted by TD Cowen from $135.00 to $138.00 in a research report report published on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the industrial products company’s stock.

Other research analysts have also recently issued research reports about the company. Mizuho boosted their price target on Xylem from $110.00 to $135.00 and gave the stock a neutral rating in a research note on Friday, May 3rd. Robert W. Baird upped their price objective on Xylem from $151.00 to $155.00 and gave the company an outperform rating in a research note on Friday, May 3rd. Oppenheimer upped their price objective on Xylem from $147.00 to $152.00 and gave the company an outperform rating in a research note on Friday, May 31st. Argus upped their price objective on Xylem from $146.00 to $165.00 and gave the company a buy rating in a research note on Wednesday, May 29th. Finally, Stifel Nicolaus upped their price objective on Xylem from $136.00 to $150.00 and gave the company a buy rating in a research note on Wednesday, February 7th. Five investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of Moderate Buy and an average price target of $142.92.

Check Out Our Latest Report on Xylem

Xylem Trading Down 2.0 %

NYSE:XYL opened at $136.87 on Thursday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.22 and a current ratio of 1.67. Xylem has a one year low of $87.59 and a one year high of $146.08. The business’s 50-day simple moving average is $135.38 and its 200 day simple moving average is $123.07. The stock has a market cap of $33.18 billion, a price-to-earnings ratio of 48.71, a price-to-earnings-growth ratio of 2.43 and a beta of 1.07.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings results on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.84 by $0.06. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The business had revenue of $2.03 billion for the quarter, compared to analysts’ expectations of $2 billion. During the same quarter in the previous year, the firm posted $0.72 earnings per share. The company’s revenue was up 40.4% compared to the same quarter last year. As a group, sell-side analysts predict that Xylem will post 4.24 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 27th. Investors of record on Thursday, May 30th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date is Thursday, May 30th. Xylem’s dividend payout ratio (DPR) is 51.25%.

Insider Buying and Selling

In related news, SVP Rodney Aulick sold 21,800 shares of the stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total value of $3,030,418.00. Following the completion of the transaction, the senior vice president now directly owns 76,287 shares of the company’s stock, valued at approximately $10,604,655.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.27% of the company’s stock.

Hedge Funds Weigh In On Xylem

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bruce G. Allen Investments LLC bought a new position in Xylem during the 4th quarter valued at $27,000. NBC Securities Inc. bought a new position in Xylem during the 3rd quarter valued at $38,000. FinTrust Capital Advisors LLC boosted its stake in Xylem by 170.9% during the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after purchasing an additional 200 shares in the last quarter. Hazlett Burt & Watson Inc. boosted its stake in Xylem by 184.9% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 220 shares in the last quarter. Finally, Orion Capital Management LLC bought a new position in Xylem during the 3rd quarter valued at $48,000. 87.96% of the stock is owned by institutional investors.

About Xylem

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Further Reading

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.